<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Plasmacytoid <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> in mice and Burkitt's <z:hpo ids='HP_0002665'>lymphomas</z:hpo> in humans display characteristic chromosomal translocations involving the c-myc proto-oncogene </plain></SENT>
<SENT sid="1" pm="."><plain>Models to explain quantitative changes in c-myc expression have been proposed based on the loss of <z:mpath ids='MPATH_458'>normal</z:mpath> promoters as a result of translocation </plain></SENT>
<SENT sid="2" pm="."><plain>However, alternative explanations, such as <z:hpo ids='HP_0001428'>somatic mutation</z:hpo> are needed to explain altered c-myc expression in the absence of gene breakage </plain></SENT>
<SENT sid="3" pm="."><plain>We present here the nucleotide sequence of the <z:mpath ids='MPATH_458'>normal</z:mpath> murine c-myc gene </plain></SENT>
<SENT sid="4" pm="."><plain>Comparison of this sequence with that of a translocated c-myc gene from a murine <z:hpo ids='HP_0011857'>plasmacytoma</z:hpo> reveals complete identity of coding sequence </plain></SENT>
<SENT sid="5" pm="."><plain>One nucleotide difference was found in the non-coding first exon </plain></SENT>
<SENT sid="6" pm="."><plain>This shows that qualitative changes of the c-myc gene product are not required for <z:e sem="disease" ids="C1326912" disease_type="Neoplastic Process" abbrv="">oncogenesis</z:e> in murine <z:hpo ids='HP_0011857'>plasmacytomas</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>In contrast, mutations are found in coding and non-coding regions of translocated c-myc genes from Burkitt's <z:hpo ids='HP_0002665'>lymphomas</z:hpo>, suggesting that the mechanisms by which c-myc is activated in <z:hpo ids='HP_0011857'>plasmacytomas</z:hpo> and Burkitt's <z:hpo ids='HP_0002665'>lymphomas</z:hpo> are different </plain></SENT>
</text></document>